Showing results (121-130 of 222) with videos related to
Sort By:
Pageof 23
British Journal of Clinical Pharmacology|June 9, 2025
Exposure-response relationship of fedratinib in patients with intermediate-2 or high-risk myelofibrosisYizhe Chen, Yan Li, Yongjun Xue, et al.Plos One|October 21, 2020
Predictors of self-reported symptoms and testing for COVID-19 in Canada using a nationally representative surveyDaphne C Wu, Prabhat Jha, Teresa Lam, et al.Health Services Research|November 26, 2015
The Green House Model of Nursing Home Care in Design and ImplementationLauren W Cohen, Sheryl Zimmerman, David Reed, et al.Plos Neglected Tropical Diseases|February 25, 2011
A low-tech analytical method for diethylcarbamazine citrate in medicated saltAbigail Weaver, Patrick Brown, Shannon Huey, et al.Rheumatology (Oxford, England)|June 9, 2017
Prenatal exposure to antimalarials decreases the risk of cardiac but not non-cardiac neonatal lupus: a single-centre cohort studyJulie Barsalou, Edgar Jaeggi, Carl A Laskin, et al.Oncotarget|October 22, 2014
Plerixafor as a chemosensitizing agent in pediatric acute lymphoblastic leukemia: efficacy and potential mechanisms of resistance to CXCR4 inhibitionEdward Allan R Sison, Daniel Magoon, Li Li, et al.American Journal of Physical Medicine & Rehabilitation|June 1, 2014
Factors associated with pressure ulcer risk in spinal cord injury rehabilitationGerben DeJong, Ching-Hui J Hsieh, Patrick Brown, et al.Plos One|April 20, 2022
Identifying the changing age distribution of opioid-related mortality with high-frequency dataLauren A Paul, Ye Li, Pamela Leece, et al.Blood|April 13, 2012
Epigenetic reprogramming reverses the relapse-specific gene expression signature and restores chemosensitivity in childhood B-lymphoblastic leukemiaTeena Bhatla, Jinhua Wang, Debra J Morrison, et al.The Journal of Clinical Investigation|February 3, 2015
Inhibition of IRAK1/4 sensitizes T cell acute lymphoblastic leukemia to chemotherapiesZhaoyang Li, Kenisha Younger, Ronald Gartenhaus, et al.Pageof 23